User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Speech
    A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with relapsed AML following a short initial complete remission
    Giles, FJ Ferrant, Augustin[UCL] Karp, J Feldman, E Daenen, S Bilgrami, SFA Cahill, A Vey, N (2006) 46th Annual Scientific Meetign of the British-Society-for-Haematology — Edinburgh (England)
    • Speech
    Arsenic trioxide in patients with myelodysplastic syndromes: A phase II multicenter study
    Vey, N Bosly, André[UCL] Guerci, A Feremans, W. Dombret, H. Dreyfus, F Bowen, D Burnett, A Dennis, M Ribrag, V. Casadevall, N. Legros, L Fenaux, P. (2006) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Rituximab given after high dose therapy and autologous stem cell transplantation induces durable clearance of minimal residual disease in about half of the patients with follicular non Hodgkin's lymphoma: 36 months results of a multicenter open label phase II trial (M39012 trial).
    Morschhauser, F. Recher, C. Milpied, N. Gressin, R Salles, G. Brice, P. Vey, N Haioun, C. Colombat, P Bourhis, JH Rossi, JF Berriot-Varoqueaux, N Bergougnoux, L Bosly, André[UCL] Delsol, G. Attal, M. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Trisenox (R) (arsenic trioxide) in patients with Myelodysplastic syndromes (MDS): Preliminary results of a phase 1/2 study.
    Vey, N Dreyfus, F Guerci, A Fenaux, P. Dombret, H. Burnett, A Bosly, André[UCL] Feremans, W. Bowen, D Garzon, F (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO(California)
    • Journal article
    Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85,-87 and-94 trials
    Dhedin, N Dombret, H. Thomas, X. Lheritier, V. Boiron, JM Rigal-Huguet, F. Vey, N Kuentz, M Reman, O. Witz, F. Delannoy, André[UCL] Kovacsovics, T Bradstock, K Charrin, C. Boucheix, C. Gabert, J. Blaise, D Fiere, D. Vernant, JP. (2006) Leukemia — Vol. 20, no. 2, p. 336-344 (2006)
    • Speech
    Trisenox (R) (arsenic trioxide) in patients with myelodysplastic syndromes (MDS): Preliminary results of a phase I/II study.
    Vey, N Dreyfus, F Guerci, A Fenaux, P. Dombret, H. Burnett, AK. Bosly, André[UCL] Feremans, W. Bowen, DT Heiskala, M (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)